How combined products address health challenges

Abstract submission for the 2022 Medtech & Pharma Platform Annual Conference (MPP2022) is open until 4 March 2022.

The one-day event will feature keynote lectures, presentations and case studies delivered by subject experts.

Call for abstracts topics

Abstracts can cover themes and topics linked to health products and combined products relating to regulatory challenges, sustainability, shortage and communication aspects. Various perspectives can be considered, such as that of the industry, patients, notified bodies and authorities. Examples of topics include the following:

Combination products

  • How to bridge the gap between the frameworks for medical devices and medicines

  • Article 117 MDR, one year on: lessons learned and challenges

  • First experiences from the implementation of the IVDR for companion diagnostics

  • Clinical studies with medicinal products and medical devices

Connected combined products

  • AI in medicines/medical devices regulation

  • Management of health data

  • Cybersecurity considerations for combined products

  • Communication and managerial organization for product development

Co-packaged/cross-labelled products

  • Combined use and labelling

  • Lifecycle management

  • Stakeholders’ responsibilities and interactions

  • Regulatory pathways

Program focus & audience

The conference program focuses on advances in the combined use of medicines and medical devices (including medical device software) to improve healthcare.


The audience includes professionals and experts from medtech, pharmaceutical, and the ICT industries, as well as regulators, notified bodies, patients organization and academia.

Author instructions

Abstract submissions must be in English and completed using the online submission form, providing the abstract category, abstract title, and the author name, function, affiliation and a short bio. Submitted abstracts of the proposed presentation should briefly summarize the investigation or observation within 250-500 words.


Novelty, key messages/learnings, and case studies/examples to be presented should be clearly stated. A maximum of two illustrations (figures and/or tables) can be included. Further details and presentation guidelines will be provided after submission. Abstracts must be submitted by 4 March 2022.